Skip to main content
. 2009 Aug 10;27(26):4247–4253. doi: 10.1200/JCO.2009.22.6993

Table A1.

Clinical Characteristics of Patients With WT/WT Genotype According to KRAS Mutation Status

Characteristic KRAS Status
P
MUT (n = 6)
WT (n = 17)
ND (n = 68)
No. % No. % No. %
Age, years .046
    Median 72 51 65
    Range 39-83 29-83 41-87
Sex .660
    Male 2 33 8 47 19 28
    Female 4 67 9 53 49 72
Smoking history .843
    Never smoker 1 17 6 35 17 25
    Light smoker 2 33 5 29 8 12
    Smoker 3 50 6 35 43 63
Ethnicity 1.000
    Asian 0 0 2 12 5 7
    Non-Asian 6 100 15 88 63 93
Pathology 1.000*
    Adeno 4 67 12 71 33 49
    BAC 1 17 2 12 29 43
    Adenosquamous 0 0 1 6 2 3
    Squamous 0 0 1 6 1 1
    Large cell/NOS 1 17 1 6 3 4
Stage 1.000
    IA 0 0 1 6 9 13
    IB 0 0 0 0 10 15
    IIA 0 0 0 0 1 1
    IIB 0 0 0 0 0 0
    IIIA 0 0 1 6 2 3
    IIIB 1 17 1 6 2 3
    IV 4 67 14 82 35 51
Multifocal BAC 1 17 0 0 9 13

Abbreviations: MUT, mutation; WT, wild type; ND, not determined; adeno, adenocarcinoma; BAC, bronchioloalveolar carcinoma; NOS, not otherwise specified.

*

Adeno and BAC v all others.

Stages I to III v IV.